Prof. Katharina Pachmann, Prof. Dr. med MD, Germany
- The science and clinical utility of CTCs as a tool to monitor the effectiveness of immunotherapy
- Are CTCs ripe for screening?
Prof. Pachmann started her scientific career with the help of an Educational grant from the German Research Foundation (Deutsche Forschungsgemeinschaft) in 1974 at the Institute for Cell Research (Institutet för Cellforskning) Karolinska Institute Stockholm Sweden followed by a Research grant from the German Research Foundation (1976-1977) at the Institute for Hematology GSF (now Helmholtz Zentrum München). She was subsequently a Research Fellow at the Institute for Hematology GSF (now Helmholtz Zentrum München) from 1977 to 1982 followed by positions at the Klinikum rechts der Isar, Munich and Klinikum Innenstadt der Ludwig-Maximilians Universität, Munich. From 1996 to 1998 she was visiting scientist at the MD Anderson Cancer Center Houston Texas Section of Molecular Hematology and Therapy followed by 12 years as a Professor for Experimental Hematology and Oncology at the University of Jena.
Since 2012 she has been responsible for research at the Transfusion Center Bayreuth, Germany. Her key discoveries are the detection, quantitative determination and characterisation of tumour cells disseminated from solid tumours into the peripheral blood. The response of these cells to therapy correlates with clinical outcome and recently the possibility to clonally expand stem-like cells from these tumour cells circulating in the blood has been explored... More info
Dr. Tim Ewer MB ChB, MSc, MRCP, FRACP, FRNZCGP, DCH, DRCOG, Dip Occ Med, FACNEM, New Zealand
Lecture: Sono-Photodynamic Therapy in cancer management
Dr Tim Ewer is one of New Zealand’s most experienced, and highly regarded integrative doctors.
Tim has been working in the field of integrative medicine for over 25-years and has established the Mapua Health Centre near Nelson where he works with his team, offering training opportunities for final year medical students, junior hospital doctors and GP Registrars.
Originally trained in the UK, Tim worked as a hospital physician for a decade after gaining his medical degree and specialist qualifications. He then went on to further study in the fields of nutrition, environmental medicine, hyperbaric medicine, acupuncture, bio-energetic medicine, holding post-graduate qualifications in paediatrics, obstetrics and gynaecology, and occupational medicine.
Tim is a long-standing supporter of ACNEM and the broader nutritional and environmental medicine community, and we are thrilled to have him speak at this event. He will be discussing Sono-Photodynamic Therapy (SPDT) in cancer management at the Genostics cancer conference in October 2018. With his broad clinical experience, Tim can offer like-minded practitioners valuable tools to empower patients... more info
Dr. med Jürgen Arnhold, Germany
Lecture and workshop: Botanical immunodrugs: indications for use in immunomodulatory cancer therapies
My objective is to offer the most advanced technologies and therapies which are currently available. Immediate and direct access to leading medical professionals, with care tailored to the individual patient’s needs.
- Prevention: Holistic treatment of disorders and assessment of personal risk with scientifically based treatment procedures for biological substances.
- Acute diseases: Advice and therapy taking into account the newest treatment approaches from science and research. The effectiveness of standard treatments will be monitored and risks assessed.
- Palliation: Treatment according to the principle of maintaining quality of life and personal integrity.
Click here for more info
Prof. Shinichiro Akiyama MD, PhD, FACP
Saisei Mirai Clinics & McGill University
Lecture: Dendritic cell vaccines and NK cells in cancer immunotherapy
Shinichiro Akiyama currently is General Director of the Saisei Mirai Clinic in Tokyo, Japan. He had been a fellow in Oncology at Sapporo Medical University School of Medicine. This led to clarify intracellular TNF as a resistant factor by chemotherapeutic agents. He joined the Cancer Immune Cell Therapy Center of Kudan Clinic in 2009. There he had applied cancer gene profiling as therapeutic effect of peptide-pulsed dendritic cell therapy. He was selected as “Featured Global Expert Cancer Researcher of Marquis Who's Who” in 2015.
Recently immunotherapy has become an attractive new strategy in the treatment of cancer, boosting the patient's own immune system to eradicate cancer cells. The toxicities of immunotherapy for cancer are as diverse as the type of treatments that have been devised. Immune surveillance by macrophage is critical for the immune integrity since invertebrates has evolved and is imposed through an intricate armory of functions that can infiltrate into tumors tissue. Oral colostrum macrophage-activating factor (MAF) produced from bovine colostrum derived vitamin D binding protein has shown high macrophage phagocytic activityas well as anti-tumor activities. Oral colostrum MAF stimulates macrophage whereas its precious mechanism has not yet been understood. It is administered orally in an acid-resistant enteric capsule to activate macrophages in the gut-associated lymphoid tissue and as a powder in the mouth to activate macrophages in the lymphoid tissue of the Waldeyer's tonsillar ring. In terms of practical clinical use, oral colostrum MAF has certain advantages over MAF produced from serum because it is derived from bovine colostrum and it is administered orally and sub-lingually instead of injection. We propose that oral colostrum MAF and MAF produced from serum could demonstrate a greater immunotherapeutic activity than that of serum MAF alone. We have also treated cancer patients with oral colostrum MAF in combination with cancer gene therapy and/or NK cell therapy so as to induce higher potential benefit of solid cancer therapy.
Dr. Stefan Schuster, Germany
Lecture title: to be confirmed
Dr Stefan Schuster started at SIMFO in 2013 as assistant to the board and gained a lot of experience in molecular diagnostics. Since 2015 he joined the board of management of SIMFO GmbH. He is responsible for scientific collaborations and economic partnerships worldwide, i.e. DKFZ, Heidelberg Germany, training of physicians as well as the further development of the maintrac method. In 2015 he successfully initiated collaboration together with the University of Bayreuth funded by the German Ministry for economics. Also in 2015 he was accountable for several EU funded H2020 projects. During the past years he developed the product strategy of SIMFO/maintrac. 2013 he was awarded as one of the best seven business plans of the Bavarian State Government (BPWN competition). In the past years he attended several congresses and held successfully lectures and published articles about circulating tumor cells. From 2009 to 2013 he worked as research associate at the University of Erlangen at the Institute of Medicinal Chemistry. He developed assay systems to study the influence of functional selective ligands. He laid there his foundation to work in the field of molecular biology. In 2008 he was an intern at Novartis Pharma GmbH and gained first experiences in the field of marketing and clinical development. He studied pharmacy at the University of Erlangen, Germany, from 2003 to 2007.
Kaytee Boyd, New Zealand
Lecture: The influence of diet in cancer immunotherapy
Kaytee has been involved in the Health and Wellness industry for over 25 years. After graduating from Otago University with a double degree in Human Nutrition and Sport Science, A member of Nutrition Society of NZ, MINND foundation, is also a DAN practitioner working with Autism. Kaytee has continued on with further study within CHEK Institute - Holistic Lifestyle Coaching disciplines, ACNEM, as well as being awarded a Prime Minister’s Scholarship to for further study over the coming years.
She was an advisor on the board of Breast Cancer Network (foundation) which was established to create resources for cancer patients.
Currently Kaytee runs two busy clinics in Auckland and runs day and weekend masterclass workshops on all things cancer based, for patients, nutritionists, dietitians, health care staff/nurses, their friends and family and anyone interested in prevention or upskilling.
Ranging from fundamental principles to specific diet interventions, lifestyle and circadian manipulation, immune support, hormone balancing, importance of glucose IGF-1 and insulin control, chemo-sensitizing agents to biohacking of genetic expression of healthy cells to create optimal health.
A retired professional athlete herself, Kaytee has competed for New Zealand in BMX, Mountain Bike, Road racing and is a World Cup Gold Medalist in Track cycling, she has also competed in the Commonwealth Games. Her skill base has great depth and knowledge of the human body making it extremely helpful in diagnosis and treatment, as well as constructing exercise programs.
Dr. Ian Dettman PhD (Biochemistry, Monash Uni), BSc(Hons), FRMIT (Microbiology, Biochemistry), ND. FANTA, FACBS, RACI, MASM, AIMS, PSA, SHPA, ACNEM (Life member), ACMN (Founder), AIMN (Founder), ATMS., Australia
Lecture: High-dose Vitamin C in the era of precision medicine and immunotherapy
Initially, Ian studied the first two years of the Pharmacy course at the Victorian College of Pharmacy before completing tertiary qualifications in Biochemistry, Microbiology and Genetics at RMIT. Ian then became interested in medical research and completed a BSc (Hon.) degree, followed by a Doctorate (into the Biochemistry of connective tissue, especially proteoglycans and collagen) at Monash University. This study involved research into arthritis and ageing. He then joined his father, Dr Glen Dettman, at their family business, Oakleigh Pathology Service. Over the course of fifteen years he gained extensive hands-on experience in biochemistry, microbiology and haematology. In the latter years, Ian managed the pathology and helped it gain NATA accreditation. Ian became a Registered Pathology Practitioner. During the course of this 15 years (1973-1988), Ian became involved in Vitamin C research with Dr Glen Dettman and Dr Archie Kalokerinos. This research continues to this day. He personally developed patents concerning the manufacture of Vitamin C and extended his knowledge of nutrition, diet and lifestyle by becoming qualified as a Natural Therapist, in which he has continued to practise for the last 20 years. Ian also became a governor of the prestigious Southern School of Natural Therapies, where he sat on numerous committee meetings concerned with course content and natural therapies registration. Ian has lectured to Doctors, tutored in Biochemistry to medical students at Monash University, and lectured to students at the Southern School of Natural Therapies. He has co-authored numerous papers as well as the book Vitamin C - Nature’s Miraculous Healing Missile with his father Dr Glen Dettman, and Dr Archie Kalokerinos.
Ian was privileged and honoured to meet Professor Linus Pauling (the only person to have won two unshared Nobel prizes) at his home in Big Sur, California in November 1993. Ian and Glen received a grant from the Linus Pauling Institute for a research project to test Vitamin C levels on newborn babies delivered at a Community Hospital. Results were published in The Australian Nurses Journal.
Prof. Luis Vitetta, Australia
University of Sydney
Lecture: The microbiome in cancer immunotherapy: therapeutic strategies
Research interests: Clinical epidemiology / The human microbiome / Probiotics and Prebiotics / Cellular redox potential and pro-oxidant signaling systems. Click here for publications.
Dr. Christine Houghton PhD., R.Nutr, Australia
Lecture: The clinical use of Sulforaphane in hormone dependent malignancies
Dr Christine Houghton holds a PhD in Nutrigenomics and a BSc in Biochemistry from the University of Queensland as well as a Graduate Diploma in Human Nutrition from Deakin University in Victoria. She is a registered Nutritionist and holds the position of Adjunct Lecturer in the School of Human Movement and Nutrition Science at the University of Queensland.
Christine is the founding director of the Brisbane company Cell-Logic which researches and
manufactures nutrigenomic ingredients for clinical application. The company’s focus is around
potentially therapeutic bioactives derived from broccoli sprouts.
In addition to her published works, she is the co-author of two evidence-based Nutrigenomics
courses: Foundations in nutrigenomics and advanced translational nutrigenomics, both self-paced online courses for practising clinicians.
Dr. Mark Donohoe, Australia
Lecture: The conversation between cancer and the immune system in 2018 and beyond
Dr. Mark Donohoe is one of Australia’s most experienced and best known medical practitioners in the fields of Nutritional and Environmental Medicine. He has a long history working in the emerging field of “integrative medicine”, and continues to bring orthodox & complementary medicine together in his Cremorne medical practice..
The underlying philosophy of Dr Donohoe’s practice is that knowledge and understanding provide people with the ability to manage their own health, and even to heal themselves.
Understanding the contribution of stress, nutrition, the work and home environment and genetics to health and illness provides the best opportunities to make specific and profound changes often required to return to health.
Dr Donohoe’s experience and knowledge of complex medical conditions, and his use of orthodox & complementary modalities and management options approach to identifying and managing chronic illness…more info
Dr. Ashley Berry, Australia
Lecture: Relevant physical signs in cancer patients
Graduated UNSW (1979) His major interest is nutritional/complementary medicine. He believes that most chronic illnesses can be improved through a nutritional focus: CFS, fibromyalgia, cancer prevention and treatment, diabetes, heart disease, insulin resistance, IBS and hormonal problems.
Dr. Joachim Fluhrer
Lecture: Case presentation
Dr Joachim Fluhrer is a medical practitioner who is widely regarded as a leader in the field of integrative and personalised medicine.
His particular interest is personalised cancer management and the early adoption into clinical practice of evidence-based liquid biopsy and tumour profiling. He currently incorporates liquid biopsy into his own practice, sourcing the most advanced, sensitive, specific and clinically validated technology internationally and advocating for the technique through national and online seminars and practitioner education.
Dr Fluhrer is considered one of Australia’s most experienced practitioners and educators in combining nutritional and environmental medicine with standard medical practice. As a senior lecturer, he has presented at seminars and conferences nationally and internationally for more than 30 years.
His positions include member of the Cancer Research Network, Sydney University, Faculty Member of the Australasian College for Medical Nutrition, board member of the Australasian Integrative Medical Association, Vice-President of the Australian College for Nutritional and Environmental Medicine (1999-2007) and committee member of the Australian Pharmaceutical Advisory Council (2003-2004). More info.